Role of ARBs in the blood hypertension therapy and prevention of cardiovascular events

Current Drug Targets

Volumn 10, Issue 1, 2009, Pages 20-25

  Novo, S ^a,b   Lunetta, M ^a   Evola, S ^a   Novo, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

ACE inhibitors; ARBs; Heart failure; Hypertension; Renin angiotensin aldosterone system

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; EPROSARTAN; IRBESARTAN; LISINOPRIL; NITRENDIPINE; PLACEBO; RAMIPRIL; TELMISARTAN; VACCINE; VALSARTAN; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ANGIONEUROTIC EDEMA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; COUGHING; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERKALEMIA; HYPOTENSION; INCIDENCE; INDUSTRIALIZATION; KIDNEY DYSFUNCTION; KIDNEY INJURY; MEDLINE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SYNCOPE; CEREBROVASCULAR DISEASE; COST BENEFIT ANALYSIS; DRUG ANTAGONISM; ECONOMICS; ENZYMOLOGY; HEART DISEASE; HYPERTENSION; METABOLISM; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; HEART DISEASES; HUMANS; HYPERTENSION; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, ANGIOTENSIN; TREATMENT OUTCOME;

EID: 63049092133     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945009787122897     Document Type: Review

References (56)

1. Wood, D.; De. Backer, G.; Faergemann, O.; Graham, I.; Mancia, G.; Pyorala, K. (1998) Eur. Heart J., 19, 1434-503.
2. Ezzati, M.; Lopez, A.D.; Rodgers, A.; Vander Hoorn, S.; Murray, C.J.; Comparative Risk Assessment Collaborating Group. (2002) Lancet, 360 (9343), 1347-60.
3. Kannel, W.B. (1996) JAMA, 275 (20), 1571-6.
4. Lewington, S.; Clarke, R.; Qizilbash, N.; Peto, R.; Collins, R. (2002) Lancet, 360 (9349), 1903-13.
5. Wolf-Maier, K.; Cooper, R.S.; Banegas, J.R.; Giampaoli, S.; Hense, H.W.; Joffres, M.; Kastarinen, M.; Poulter, N.; Primatesta, P.; Rodríguez-Artalejo F.; Stegmayr, B.; Thamm, M.; Tuomilehto, J.; Vanuzzo, D.; Vescio, F. (2003) JAMA, 289 (18), 2363-9.
6. Lawes, C.M.M.; Vander Hoorn, S.; Law, M.R.; Elliott, P.; MacMahon, S.; Rodgers, A. (2006) J. Hypertens, 24, 423-30.
7. Clement, D.L.; De Buyzere, M.L.; De Bacquer, D.A.; De Leeuw, P.W.; Duprez, D.A.; Fagard, R.H.; Gheeraert, P.J.; Missault, L.H.; Braun, J.J.; Six, R.O.; Van Der Niepen, P.; O'Brien, E.; Office versus Ambulatory Pressure Study Investigators. (2003) N. Engl. J. Med., 348, 2407-15.
8. Veterans Administration Cooperative Study Group on antihypertensive agents. (1970) JAMA, 213, 1143-52.
9. ESH-ESC Guideline for treatment of Hypertension. (2003) J. Hypertens, 21, 1011-53.
10. Lindholm, L.H.; Ibsen, H.; Dahlöf, B.; Devereux, R.B.; Beevers, G.;, De Faire, U.; Fyhrquist, F.; Julius, S.; Kjeldsen, S.E.; Kristiansson, K.; Lederballe-Pedersen, O.; Nieminen, M.S.; Omvik, P.; Oparil, S.; Wedel, H.; Aurup, P.; Edelman, J.; Snapinn, S. LIFE Study Group. (2002) Lancet, 359 (9311), 1004-10.
11. Schrader, J.; Lüders, S.; Kulschewski, A.; Hammersen, F.; Plate, K.; Berger, J.; Zidek, W.; Dominiak, P.; Diener, H.C.; MOSES Study Group. (2005) Stroke, 36 (6), 1218-26.
12. Lithell, H.; Hansson, L.; Skoog, I.; Elmfeldt, D.; Hofman, A.; Olofsson, B.; Trenkwalder, P.; Zanchetti, A.; SCOPE Study Group. (2003) J. Hypertens, 21, 875-6.
13. Schrader, J.; Lüders, S.; Kulschewski, A.; Berger, J.; Zidek, W.; Treib, J.; Einhäupl, K.; Diener, H.C.; Dominiak, P. (2003) Stroke, 34 (7), 1699-703.
14. Klingbeil, A.U.; Schneider, M.; Martus, P.; Messerli, F.H.; Schmieder, R.E. (2003) Am. J. Med., 115 (1), 41-6.
15. Cuspidi, C.; Muiesan, M.L.; Valagussa, L.; Salvetti, M.; Di Biagio, C.; Agabiti-Rosei, E.; Magnani, B.; Zanchetti, A. (2002) J. Hypertens., 20 (11), 2293-300.
16. Solomon, S.D.; Janardhanan, R.; Verma, A.; Bourgoun, M.; Daley, W.L.; Purkayastha, D.; Lacourcière, Y.; Hippler, S.E.; Fields, H.; Naqvi, T.Z.; Mulvagh, S.L.; Arnold, J.M.; Thomas, J.D.; Zile, M.R.; Aurigemma, G.P. (2007) Lancet, 369 (9579), 2079-87.
17. Frampton, J.E.; Curran, M.P. (2007) Drugs, 67 (12), 1767-92.
18. Corrado, E.; Rizzo, M.; Muratori, I.; Coppola, G.; Novo, S. (2006) Arch. Med. Res., 37 (8), 1004-9.
19. Lakoski, S.G.; Cushman, M.; Palmas, W.; Blumenthal, R.; D'Agostino, R.B. Jr; Herrington, D.M. (2005) J. Am. Coll. Cardiol., 46 (10), 1869-74.
20. Novo, S.; Abrignani, M.G.; Liquori, M.; Corda, M.; Pinto, A.; Cosentino, F.; Strano, A. (1991) J. Hypertens, 9 (Suppl. 6), S 202-S 203.
21. Volpe, M.; Castello, L.; Cosentino, F. (2007) High Blood Press. Cardiovasc. Prevent., 14 (4), 221-7.
22. Fliser, D.; Buchholz, K.; Haller, H.; European Trial Olmesartan and Pravastin in Inflammation and Atherosclerosis (EUTOPIA) Investigators. (2004) Circulation, 110 (9), 1103-7.
23. Smith, R.D.; Yokoyama, H.; Averill, D.B.; Cooke, L.; Brosnihan, K.B.; Schiffrin, E.L.; Ferrario, C.M. (2006) Am. J. Cardiovasc. Drugs, 6 (5), 335-42.
24. Stumpe, K. The Multicentric Olmesartan atherosclerosis Regression Study (MORE). Oral Presentation at satellite symposium entitled plaque, vascular structure and angiotensin receptor blockade, held at the World Congress of Cardiology. 2006 Sep 2-6, Barcelona
25. Chon, J.N.; Tognoni, G.; Valsartan Heart Failure Trial (Val-HeFT) Investigators. (2001) N. Engl. J. Med., 345 (23), 1667-75.
26. ANMCO - Associazione Nazionale Medici Cardiologi Ospedalieri; SHAPE - Gruppo di Studio Europeo sullo Scompenso Cardiaco. Press Release, 2006 June 28, Rome.
27. Mochizuki, S.; Dahlöf, B.; Shimizu, M.; Ikewaki, K.; Yoshikawa, M.; Taniguchi, I.; Ohta, M.; Yamada, T.; Ogawa, K.; Kanae, K.; Kawai, M.; Seki, S.; Okazaki, F.; Taniguchi, M.; Yoshida, S., Tajima, N.; Jikei Heart Study group. (2007) Lancet, 369 (9571), 1431-9.
28. McKelvie, R.S.; Yusuf, S.; Pericak, D.; Avezum, A.; Burns, R.J.; Probstfield, J.; Tsuyuki, R.T.; White, M.; Rouleau, J.; Latini, R.; Maggioni, A.; Young, J.; Pogue, J. (1999) Circulation, 100 (10), 1056-64.
29. Pfeffer, M.A.; Swedberg, K.; Granger, C.B.; Held, P.; McMurray, J.J.; Michelson, E.L.; Olofsson, B.; Ostergren, J.; Yusuf, S.; Pocock, S. CHARM Investigators and Committees. (2003) Lancet, 362 (9386), 759-66.
30. Ducharme, A.; Swedberg, K.; Pfeffer, M.A.; Cohen-Solal, A.; Granger, C.B.; Maggioni, A.P.; Michelson, E.L.; McMurray, J.J.; Olsson, L.; Rouleau, J.L.; Young, J.B.; Olofsson, B.; Puu, M.; Yusuf, S.; CHARM Investigators. (2006) Am. Heart J., 152 (1), 86-92.
31. Healey, J.S.; Baranchuk, A.; Crystal, E.; Morillo, C.A.; Garfinkle, M.; Yusuf, S.; Connolly, S.J. (2005) J. Am. Coll. Cardiol., 45 (11), 1832-9.
32. Aksnes, T.A.; Flaa, A.; Strand, A.; Kjeldsen, S.E. (2007) J. Hypertens., 25 (1), 15-23.
33. Mancia, G.; Grassi, G.; Zanchetti, A. (2006) J. Hypertens., 24 (1), 3-10.
34. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) Blood Press., 16, 135-232.
35. Stamler, J.; Vaccaro, O.; Neaton, J.D.; Wentworth, D. (1993) Diabetes Care, 16 (2), 434-44.
36. Yusuf, S.; Teo, K.K.; Pogue, J.; Dyal, L.; Copland, I.; Schumacher, H.; Dagenais, G.; Sleight, P.; Anderson, C.; ONTARGET Investigators. (2008) N. Engl. J. Med., 358 (15), 1547-59.
37. McMurray, J.J. (2008) N. Engl. J. Med., 358 (15), 1615-6.
38. Weir, M.R. (2007) Clin. Ther., 29 (9), 1803-24.
39. Parving, H.H.; Lehnert, H.; Bröchner-Mortensen, J.; Gomis, R.; Andersen, S.; Arner, P. (2001) N. Engl. J. Med., 345 (12), 870-8.
40. Nakao, N.; Yoshimura, A.; Morita, H.; Takada, M.; Kayano, T.; Ideura, T. (2003) Lancet., 361 (9352), 117-24.
41. Mogensen, C.E.; Neldam, S.; Tikkanen, I.; Oren, S.; Viskoper, R.; Watts, R.W.; Cooper, M.E. (2000) BMJ, 321 (7274), 1440-4.
42. Rippin, J.; Bain, S.C.; Barnett, A.H. (2002) J. Diabet. Complications, 16 (3), 195-200.
43. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2007) Can. J. Cardiol., 23, 539-50.
44. Jeantet, A.; Piccoli, G.B.; Pacitti, A.; Thea, A.; Maffei, S.; Malfi, B.; Gai, M.; Bermond, F.; Burdese, M.; Bechis, F.; Mezza, E.; Segoloni, G.P.; Piccoli, G. (2002) Giornale Italiano di Nefrologia, 19, 308-31.
45. Turnbull, F.; Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC). (2003) Lancet, 362 (9395), 1527-35.
46. Mallion, J.M.; Carretta, R.; Trenkwalder, P.; Martinez, J.F.; Tykarski, A.; Teitelbaum, I.; Oddou, P.; Fagan, T.; Co-Diovan Study Group. (2003) Blood Press Suppl., 1, 36-43.
47. Wolf-Maier, K.; Cooper, R.S.; Kramer, H.; Banegas, J.R.; Giampaoli, S.; Joffres, M.R.; Poulter, N.; Primatesta, P.; Stegmayr, B.; Thamm, M. (2004) Hypertension, 43 (1), 10-17.
48. Mancia, G.; Bombelli, M.; Lanzarotti, A.; Grassi, G.; Cesana, G.C.; Zanchetti, A.; Sega, R. (2002) Arch. Intern. Med., 162 (5), 582-6.
49. Bloom, B.S. (1998) Clin. Ther., 20 (4), 671-81.
50. Prasad, P.P.; Yeh, C.M.; Gurrieri, P.; Glazer, R.; McLeod, J. (2002) J. Cardiovasc. Pharmacol., 40 (5), 801-7.
51. Matchar, D.B.; McCrory, D.C.; Orlando, L.A.; Patel, M.R.; Patel, U.D.; Patwardhan, M.B.; Powers, B.; Samsa, G.P.; Gray, R.N. (2008) Ann. Intern. Med., 148 (1), 16-29.
52. Tissot, A.C.; Maurer, P.; Nussberger, J.; Sabat, R.; Pfister, T.; Ignatenko, S.; Volk, H.D.; Stocker, H.; Müller, P.; Jennings, G.T.; Wagner, F.; Bachmann, M.F. (2008) Lancet, 371 (9615), 821-7.
53. Ambrosioni, E.; Leonetti, G.; Pessina, A.C.; Rappelli, A.; Trimarco, B.; Zanchetti, A. (2000) J. Hypertens, 18 (11), 1691-9.
54. Halpern, M.T.; Luce, B.R.; Brown, R.E.; Geneste, B. (1998) Value Health, 1 (2), 131-47.
55. Cramer, J.A.; Benedict, A.; Muszbek, N.; Keskinaslan, A.; Khan, Z.M. (2008) Int. J. Clin. Pract., 62 (1), 76-87.
56. Sokol, M.C.; McGuigan, K.A.; Verbrugge, R.R.; Epstein, R.S. (2005) Med. Care, 43 (6), 521-30.